<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03505580</url>
  </required_header>
  <id_info>
    <org_study_id>P01.001.07</org_study_id>
    <nct_id>NCT03505580</nct_id>
  </id_info>
  <brief_title>AMIStem-H Radiological Assessment</brief_title>
  <official_title>Etude rétrospective et Prospective, Multicentrique, Non contrôlée, Non randomisée, Ouverte évaluant la Performance et la sécurité de l'Implant AMIStem</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medacta International SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medacta International SA</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate radiological performance of the cementless femoral&#xD;
      stem AMIStem H at 1 and 5-year follow-up.&#xD;
&#xD;
      All the patients operated at the investigational sites between April 2009 and April 2012 will&#xD;
      be reviewed at 1, 5 and 10 year according to standard practice&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of radiolucencies</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>correlation between the presence of radiolucencies and patient/implant characteristics</measure>
    <time_frame>5 years, 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>evaluation of radiolucent lines progression</measure>
    <time_frame>1 years, 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>evaluation of radiolucent lines progression</measure>
    <time_frame>5 years, 10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Record of adverse events</measure>
    <time_frame>1, 5 years and 10 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Hip Replacement Arthroplasty</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All the patients who undewent total hip arthroplasty with AMIStem-H cementless femoral stem&#xD;
        at the investigational sites between April 2009 and April 2012&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients who underwent total hip arthroplasty at the investigational sites between&#xD;
             April 2009 and April 2012&#xD;
&#xD;
          -  patients bearing an AMIStem-H cementless femoral stem&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients who refuse to give consent for the treatment of data&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Clinique du Cèdre</name>
      <address>
        <city>Bois Guillaume</city>
        <zip>76230</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal Viè</last_name>
      <phone>+33 2 35 59 59 59</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Paris V</name>
      <address>
        <city>Paris</city>
        <zip>75005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederic Laude</last_name>
      <phone>+33 826 30 75 05</phone>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>April 16, 2018</study_first_submitted>
  <study_first_submitted_qc>April 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2018</study_first_posted>
  <last_update_submitted>September 1, 2020</last_update_submitted>
  <last_update_submitted_qc>September 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

